Walleye Capital’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Other funds holding VTYX
Walleye Capital's VTYX Position: Q1 2026 in Review
Walleye Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 4,080 shares — an estimated $36.8K sold.
Walleye Capital first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $4.09M in Q4 2022. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Walleye Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Walleye Capital sold 4,080 Ventyx Biosciences shares in Q1 2026, an estimated $36.8K.
- Walleye Capital first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
- Walleye Capital's Ventyx Biosciences position peaked at $4.09M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.